Pacira BioSciences, Inc. (82P.F)

25,00 +1,20 (+5,04%) Ab 09:03AM CEST. Markt geöffnet.

Pacira BioSciences, Inc.

5401 West Kennedy Boulevard
Suite 890
Tampa, FL 33609
United States
813 553 6680
https://www.pacira.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 711

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Daryl Gaugler	Chief Operating Officer	730,13k	107,82k	1962
Ms. Kristen Williams J.D.	Chief Administrative Officer & Secretary	749,69k	804,13k	1974
Mr. Anthony Molloy III, Esq.	Chief Legal & Compliance Officer	545,1k	751,98k	1974
Mr. David M. Stack	Advisor	1,45M	4,1M	1950
Mr. Frank D. Lee	CEO & Director	N/A	N/A	1968
Ms. Lauren Bullaro Riker	Principal Accounting Officer & Senior VP of Finance	270,78k	184,32k	1979
Susan Mesco	Head of Investor Relations	N/A	N/A	N/A
Mr. Richard Kahr	Vice President of Human Resources	N/A	N/A	N/A
Dr. Jonathan Slonin M.D.	Chief Medical Officer	764,33k	N/A	1975
Mr. Christopher C. Young	Chief Manufacturing Officer	N/A	N/A	1972

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Corporate Governance

Pacira BioSciences, Inc.s ISS Governance QualityScore, Stand 29. April 2024, lautet 5. Die grundlegenden Scores sind Audit: 1, Vorstand: 6, Shareholderrechte: 7, Kompensation: 5.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.